We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Aqua Bty Reg S | ABTX | London | Ordinary Share |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 12.50 | 01:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 12.50 |
| Top Posts |
|---|
Posted at 27/3/2013 21:38 by xcap LUFCS, thanks for postingexcellent read and good PR for ABTX |
Posted at 26/3/2013 20:22 by xcap Lufcs/gozcare to put any revenue figures on the sale of the salmon eggs and how big the market could be for ABTX |
Posted at 16/2/2013 16:19 by xcap all good points chaps.if share price drops further I'll be buying Captain Kirk will have to pay a decent price now for a take out imho whatever the outcome. He's confirmed that he is content that the bio-technology is valid, clearly works and is safe, otherwise why buy into ABTX. If refused (hopefully an unlikely outcome) he may take the company out and take the technology to a country(s) that will approve, for example the African nations and come out smelling of roses as a commercial philanthropist (obvioulsy won't being doing it without profit) |
Posted at 15/1/2013 16:11 by lufc5 The first GM animal could help feed the worldEver since dwarfs and Siamese twins have been paraded as circus entertainment, we have been fascinated by so-called freaks of nature. But only now are we starting to understand the genetic causes. The first sequencing of the human genome took ten years, cost $3bn and was completed in 2003. Since then there has been an extraordinary advance in our ability to sequence the genome of living things, from the human body down to the humblest bacteria. All over the world biotechnologists are mapping genomes, the recipe for life. Armed with this knowledge, it is possible to alter the recipe through genetic manipulation, and today genetically modified crops are grown in over 40 countries. Take this example... Just before Christmas I spotted one of the most significant announcements of 2012, from Aqua Bounty Technology Inc (ABTX), a US company that has its shares traded on AIM. The US Food and Drug Administration has indicated its inclination to approve Aqua Bounty's AquAdvantage Salmon, having found that they are safe to eat and do not pose a threat to the environment. These salmon are created by inserting the growth hormone gene from the Chinook salmon into Atlantic salmon eggs, which allows them to reach market size in half the time of conventional Atlantic salmon. Furthermore, and to heed off any criticism that they could breed with and destroy natural salmon, these genetically engineered fish will be sterile, exclusively female and grown in landlocked pools. This salmon could be the first GM animal to hit the dinner table. That is stunning news for diners, for farmers, for all those concerned with feeding the world's population and for biotechnology. I strongly believe there are huge profits to be made in biotechnology. It is a topic I have become fascinated with in the last couple of years. That's why I am going to offer you a unique chance of exploiting this booming industry with me. Very soon I'll show you where you could make huge profits in this rapidly growing industry. I'll be sending you details of how you can join me on this journey in the coming month or so. Stay tuned. Good investing, Tom Bulford The Penny Sleuth |
Posted at 07/1/2013 09:47 by lufc5 Here we go guys...shows how tightly this is held...they couldn't even get that 2.5%. Great news imo.7 January 2013 AquaBounty Technologies, Inc. ("AquaBounty" or "the Company") Update on Proposed Tender Offer by Intrexon Further to the announcement of 5 December 2012, AquaBounty Technologies, Inc. (AIM: ABTX), a biotechnology company focused on enhancing productivity in the aquaculture market, provides an update on the tender offer ("the Offer") by Intrexon Corporation ("Intrexon"), a privately held biotechnology company, to shareholders to purchase the issued and outstanding share capital of the Company not owned by Intrexon. In accordance with the terms of AquaBounty's Certificate of Incorporation, the Offer was conditional on receiving acceptances in respect of shares that, together with Intrexon's holding of 47.56%, will result in Intrexon holding shares constituting more than 50% of the issued and outstanding shares of AquaBounty common stock. The acceptances combined with Intrexon's current holding did not meet this threshold. As such, the conditions of the Offer have not been met and Intrexon will not acquire the common shares tendered in the Offer. Those AquaBounty shareholders who accepted the Offer and tendered their shares will have returned to them their relevant share certificates and other documents of title in accordance with the terms of the Offer. As stated in the Offer document, pursuant to the terms of the Relationship Agreement, Intrexon has the right, based on its current ownership, to appoint three of the six directors to AquaBounty's board of directors (the "Board"). When the nomination process has concluded, AquaBounty will announce to the market the Intrexon designees to the Board. |
Posted at 27/12/2012 16:53 by lufc5 Maybe just a distant pipedream but, it is certainly a possibility(given Randal's previous record) that Intrexon/ABTX could get snaffled up by one of these majors in the future. I for one, certainly wouldn't bet against it. |
Posted at 27/12/2012 15:02 by lufc5 I can't get an online quote at all now.Bodes well for current holders imho. Ps. I'll bet the yanks arn't even aware that ABTX' is a listed co'. That may be a weekend promotion job. ;o) |
Posted at 27/12/2012 11:44 by bronislav I suspect Intrexon had been tipped off.49per cent and lend abtx to keep them afloat.The date of the environemental statement is around about the time that the fda spokesmen made the soon remark about that timing of the environemental statement.politics at play and the usual dishonesty attached to the stock exchange .looking good from here. |
Posted at 27/12/2012 11:20 by lufc5 Seems he has a track record of picking fledgling bio techs with huge potential(just like ABTX).Pretty much self made. |
Posted at 25/12/2012 07:29 by xcap a favourable report could see this stock hit a £1 easily imho its like an oily striking a multi million barrel find it would be transformational in food/fish production globally especially for underdevloped countries, well done ABTX and fingers crossed. get the feeling they might just do it! merry christmas all |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
